Varan, A. Et Al. 2007. Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification. PEDIATRIC BLOOD & CANCER , vol.49, no.4 , 484.

Varan, A., Ozyar, E., Gultekin, M., Corapcioglu, F., Koksal, Y., AYDIN, G. B., ... Akyuz, C.(2007). Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification. PEDIATRIC BLOOD & CANCER , vol.49, no.4, 484.

Varan, Ali Et Al. "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification," PEDIATRIC BLOOD & CANCER , vol.49, no.4, 484, 2007

Varan, Ali Et Al. "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification." PEDIATRIC BLOOD & CANCER , vol.49, no.4, pp.484, 2007

Varan, A. Et Al. (2007) . "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification." PEDIATRIC BLOOD & CANCER , vol.49, no.4, p.484.

@article{article, author={Ali Varan Et Al. }, title={Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification}, journal={PEDIATRIC BLOOD & CANCER}, year=2007, pages={484} }